Event organised by the Alliance for Regenerative Medicine (ARM). The will event will include ARM’s annual yearly update on the sector’s progress as well as sessions highlighting future inflection points for cell and gene therapies in the coming year.
Online
Ask for a Free trial and get access to the latest stories
Our coverage includes:
- Health Care
- Market Access
- HTA – policies & practices
- European medicine regulations
- Drug safety issues
- Pricing & Reimbursement
- International medicines agencies
If you are a Payer, Pharmaceutical or Consulting professional our premium data will keep you informed on the regulatory, pricing, market access and cost-effectiveness issues that impact all stakeholders.
REQUEST
an initial 10 day temporary access of APM Market Access.
